Tariff Impact on Pharma and Auto Industries

This chapter explores the proposed 25 percent tariff on pharmaceuticals and its potential to raise U.S. drug costs significantly. It highlights investment opportunities in the biotech sector while examining how major pharmaceutical companies like Lilly and Pfizer may fare amidst market volatility. Additionally, the chapter discusses changes in advertising strategies among automakers in light of tariffs, emphasizing consumer sentiment and purchasing behavior.